Theratechnologies Inc (THTX)

Theratechnologies Stock Analysis & Ratings

THTX Stock Chart & Stats

Day’s Range$2.28 - $2.41
52-Week Range$2.05 - $4.46
Previous Close$2.43
Average Volume (3M)79.05K
Market Cap$216.88M
P/E Ratio-6.2
Next EarningsJul 14, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score6
EPS (TTM)-0.37



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Theratechnologies’s price range in the past 12 months?
Theratechnologies lowest stock price was $2.05 and its highest was $4.46 in the past 12 months.
    What is Theratechnologies’s market cap?
    Theratechnologies’s market cap is $216.88M.
      What is Theratechnologies’s price target?
      The average price target for Theratechnologies is $6.20. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $6.20 ,the lowest forecast is $6.20. The average price target represents 171.93% Increase from the current price of $2.28.
        What do analysts say about Theratechnologies?
        Theratechnologies’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Theratechnologies’s upcoming earnings report date?
          Theratechnologies’s upcoming earnings report date is Jul 14, 2022 which is in 54 days.
            How were Theratechnologies’s earnings last quarter?
            Theratechnologies released its earnings results on Apr 13, 2022. The company reported -$0.09 earnings per share for the quarter, missing the consensus estimate of -$0.07 by -$0.02.
              Is Theratechnologies overvalued?
              According to Wall Street analysts Theratechnologies’s price is currently Undervalued.
                Does Theratechnologies pay dividends?
                Theratechnologies does not currently pay dividends.
                What is Theratechnologies’s EPS estimate?
                Theratechnologies’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Theratechnologies have?
                Theratechnologies has 95,120,000 shares outstanding.
                  What happened to Theratechnologies’s price movement after its last earnings report?
                  Theratechnologies reported an EPS of -$0.09 in its last earnings report, missing expectations of -$0.07. Following the earnings report the stock price went up 3.187%.
                    Which hedge fund is a major shareholder of Theratechnologies?
                    Among the largest hedge funds holding Theratechnologies’s share is Fisher Asset Management LLC. It holds Theratechnologies’s shares valued at 49K.


                      Theratechnologies Stock Analysis

                      The Theratechnologies stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Theratechnologies Inc

                      Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

                      Similar Stocks
                      Price & Change
                      Trevi Therapeutics
                      Venus Concept
                      Verona Pharma
                      X4 Pharmaceuticals

                      Popular Stocks

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis